Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues

被引:104
作者
Kendall, RL [1 ]
Rutledge, RZ
Mao, X
Tebben, AJ
Hungate, RW
Thomas, KA
机构
[1] Merck Res Labs, Dept Canc Res, W Point, PA 19486 USA
[2] Merck Res Labs, Dept Mol Design & Divers, W Point, PA 19486 USA
[3] Merck Res Labs, Dept Med Chem, W Point, PA 19486 USA
关键词
D O I
10.1074/jbc.274.10.6453
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor is an important physiological regulator of angiogenesis, The function of this endothelial cell selective growth factor is mediated by two homologous tyrosine kinase receptors, fms-like tyrosine kinase 1 (Flt-1) and kinase domain receptor (KDR). Although the functional consequence of vascular endothelial growth factor binding to the Flt-1 receptor is not fully understood, it is well established that mitogenic signaling is mediated by KDR, Upon sequencing several independent cDNA clones spanning the cytoplasmic region of human KDR, we identified and confirmed the identity of a functionally required valine at position 848 in the ATP binding site, rather than the previously reported glutamic acid residue, which corresponds to an inactive tyrosine kinase, The cytoplasmic domain of recombinant native KDR, expressed as a glutathione S-transferase fusion protein, can undergo autophosphorylation in the presence of ATP. In addition, the kinase activity can be substantially increased by autophosphorylation at physiologic ATP concentrations. Mutation analysis indicates that both tyrosine residues 1054 and 1059 are required for activation, which is a consequence of an increased affinity for both ATP and the peptide substrate and has no effect on k(cat), the intrinsic catalytic activity of the enzyme. KDR kinase catalyzes phosphotransfer by formation of a ternary complex with ATP and the peptide substrate. We demonstrate that tyrosine kinase antagonists can preferentially inhibit either the unactivated or activated form of the enzyme.
引用
收藏
页码:6453 / 6460
页数:8
相关论文
共 45 条
[1]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[2]  
APRELIKOVA O, 1992, CANCER RES, V52, P746
[3]   Full activation of the platelet-derived growth factor β-receptor kinase involves multiple events [J].
Baxter, RM ;
Secrist, JP ;
Vaillancourt, RR ;
Kazlauskas, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) :17050-17055
[4]   Kinetic mechanisms of the forward and reverse pp60(c-src) tyrosine kinase reactions [J].
Boerner, RJ ;
Barker, SC ;
Knight, WB .
BIOCHEMISTRY, 1995, 34 (50) :16419-16423
[5]  
COLE PA, 1994, J BIOL CHEM, V269, P30880
[6]   ADENOSINE CYCLIC 3',5'-MONOPHOSPHATE DEPENDENT PROTEIN-KINASE - KINETIC MECHANISM FOR THE BOVINE SKELETAL-MUSCLE CATALYTIC SUBUNIT [J].
COOK, PF ;
NEVILLE, ME ;
VRANA, KE ;
HARTL, FT ;
ROSKOSKI, R .
BIOCHEMISTRY, 1982, 21 (23) :5794-5799
[7]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[8]   BIOLOGICAL-ACTIVITY AND PHOSPHORYLATION SITES OF THE BACTERIALLY EXPRESSED CYTOSOLIC DOMAIN OF THE KDR VEGF-RECEPTOR [J].
DOUGHERVERMAZEN, M ;
HULMES, JD ;
BOHLEN, P ;
TERMAN, BI .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 205 (01) :728-738
[9]   SIGNALING BY RECEPTOR TYROSINE KINASES [J].
FANTL, WJ ;
JOHNSON, DE ;
WILLIAMS, LT .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :453-481
[10]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931